You May Also Like / View all maxioms
We're talking to a lot of major groups that may not have considered us in the past.
We're talking to a lot of major groups that may not have considered us in the past.
We get a second chance at beating the No. 1 team in the country, and we're not going to turn read more
We get a second chance at beating the No. 1 team in the country, and we're not going to turn this one down. We're being given a second chance to dig deep and get this one.
[Aziz's patrol continues on past one of the two main mosques in Karmah. Over the past few days, the Iraqi read more
[Aziz's patrol continues on past one of the two main mosques in Karmah. Over the past few days, the Iraqi soldiers have told the Marines what the imams have blasted over loudspeakerscalls to rise up and attack the Americans. But, under strict orders, the Marines may not enter mosques or schools. They don't like it.] What I'd give to be able to look in there, ... You know they're hiding something.
It is fair to say he has had a tremendous positive impact on my life and my business.
It is fair to say he has had a tremendous positive impact on my life and my business.
The Clinton Administration has seemed to put more concern on scoring political points than advancing serious reform.
The Clinton Administration has seemed to put more concern on scoring political points than advancing serious reform.
She came to this country to do her job as a journalist and not anything else.
She came to this country to do her job as a journalist and not anything else.
That whose existence is necessary must necessarily be one essence.
That whose existence is necessary must necessarily be one essence.
We are praying for them and their family.
We are praying for them and their family.
[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, read more
[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, after a slow start, it grew to become a $US2.3 billion ($3 billion today) blockbuster for its owner, Pfizer, in 2003.] About 80 per cent of the prescriptions were for unapproved uses - conditions like bipolar disorder, post-traumatic stress disorder, insomnia, restless legs syndrome, hot flashes, migraines and tension headaches, ... In fact, Neurontin has become a sort of all-purpose restorative for chronic discomfort of almost any type - yet there is almost no good published evidence that it works.